National Trends In Ambulatory Care Visits For Otitis Media In Children Under The Age Of Five In The United States
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Nov 2017 Status changed from active, no longer recruiting to completed.
- 11 Oct 2017 Planned End Date changed from 31 Aug 2017 to 31 Dec 2017.
- 11 Oct 2017 Planned primary completion date changed from 31 Aug 2017 to 31 Dec 2017.